Free Trial

Bruker (BRKR) Competitors

Bruker logo
$36.34 -0.11 (-0.30%)
Closing price 04:00 PM Eastern
Extended Trading
$35.74 -0.60 (-1.65%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BRKR vs. WAT, ILMN, TECH, BIO, CRL, PACB, HBIO, TMO, A, and MTD

Should you be buying Bruker stock or one of its competitors? The main competitors of Bruker include Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Charles River Laboratories International (CRL), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), Agilent Technologies (A), and Mettler-Toledo International (MTD). These companies are all part of the "life sciences tools & services" industry.

Bruker vs.

Waters (NYSE:WAT) and Bruker (NASDAQ:BRKR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, community ranking, profitability, risk and dividends.

In the previous week, Waters had 50 more articles in the media than Bruker. MarketBeat recorded 65 mentions for Waters and 15 mentions for Bruker. Bruker's average media sentiment score of 1.08 beat Waters' score of 0.58 indicating that Bruker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Waters
24 Very Positive mention(s)
5 Positive mention(s)
27 Neutral mention(s)
6 Negative mention(s)
3 Very Negative mention(s)
Positive
Bruker
12 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Waters has higher earnings, but lower revenue than Bruker. Waters is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Waters$2.98B6.96$637.83M$11.0231.66
Bruker$3.45B1.60$113.10M$0.5270.12

Waters has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500.

Waters has a net margin of 21.56% compared to Bruker's net margin of 3.36%. Waters' return on equity of 46.31% beat Bruker's return on equity.

Company Net Margins Return on Equity Return on Assets
Waters21.56% 46.31% 15.67%
Bruker 3.36%21.01%6.46%

Waters currently has a consensus target price of $390.19, suggesting a potential upside of 11.83%. Bruker has a consensus target price of $59.10, suggesting a potential upside of 62.10%. Given Bruker's higher possible upside, analysts plainly believe Bruker is more favorable than Waters.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Waters
0 Sell rating(s)
9 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
2.61
Bruker
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45

94.0% of Waters shares are held by institutional investors. Comparatively, 79.5% of Bruker shares are held by institutional investors. 0.8% of Waters shares are held by company insiders. Comparatively, 27.3% of Bruker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Bruker received 239 more outperform votes than Waters when rated by MarketBeat users. Likewise, 64.62% of users gave Bruker an outperform vote while only 53.43% of users gave Waters an outperform vote.

CompanyUnderperformOutperform
WatersOutperform Votes
444
53.43%
Underperform Votes
387
46.57%
BrukerOutperform Votes
683
64.62%
Underperform Votes
374
35.38%

Summary

Waters beats Bruker on 11 of the 19 factors compared between the two stocks.

Get Bruker News Delivered to You Automatically

Sign up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BRKR vs. The Competition

MetricBrukerAnalytical instruments IndustryComputer SectorNASDAQ Exchange
Market Cap$5.51B$4.29B$25.27B$8.43B
Dividend Yield0.55%0.57%2.89%4.11%
P/E Ratio47.8726.5144.7719.75
Price / Sales1.603.752,072.01118.67
Price / Cash14.7436.2434.7834.62
Price / Book3.081.536.684.50
Net Income$113.10M-$84.30M$739.99M$248.32M
7 Day Performance-0.63%2.60%-0.27%0.48%
1 Month Performance-1.35%3.94%13.42%13.08%
1 Year Performance-53.43%-22.57%52,709.90%7.36%

Bruker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BRKR
Bruker
4.9311 of 5 stars
$36.34
-0.3%
$59.10
+62.6%
-52.3%$5.52B$3.45B47.828,520Dividend Announcement
Analyst Forecast
WAT
Waters
3.9433 of 5 stars
$366.80
+6.6%
$390.19
+6.4%
-1.3%$21.83B$2.98B34.258,200Trending News
Analyst Upgrade
ILMN
Illumina
4.7978 of 5 stars
$81.57
+7.7%
$130.95
+60.5%
-26.2%$12.91B$4.37B-10.6211,500Positive News
Analyst Forecast
TECH
Bio-Techne
4.844 of 5 stars
$53.90
+7.9%
$73.44
+36.3%
-43.6%$8.52B$1.21B54.443,000Positive News
Dividend Announcement
Ex-Dividend
High Trading Volume
BIO
Bio-Rad Laboratories
4.7949 of 5 stars
$254.32
+6.6%
$327.40
+28.7%
-21.1%$7.12B$2.54B-3.918,200Positive News
CRL
Charles River Laboratories International
4.9016 of 5 stars
$143.06
+3.1%
$176.00
+23.0%
-39.0%$7.03B$4.02B953.7121,400Positive News
High Trading Volume
PACB
Pacific Biosciences of California
1.6117 of 5 stars
$1.10
-1.8%
$2.50
+127.3%
-46.4%$330.05M$152.36M-0.67730
HBIO
Harvard Bioscience
3.6304 of 5 stars
$0.35
+11.8%
$4.50
+1,178.0%
-90.0%$15.57M$94.14M-1.07490Analyst Forecast
High Trading Volume
TMO
Thermo Fisher Scientific
4.9932 of 5 stars
$432.16
+7.2%
$607.43
+40.6%
-32.6%$163.14B$42.90B26.14130,000Trending News
Dividend Announcement
Analyst Upgrade
Analyst Revision
High Trading Volume
A
Agilent Technologies
4.8351 of 5 stars
$115.53
+8.0%
$143.00
+23.8%
-29.2%$32.94B$6.51B26.5617,900Trending News
Upcoming Earnings
Dividend Announcement
Analyst Forecast
MTD
Mettler-Toledo International
4.4702 of 5 stars
$1,175.33
+8.7%
$1,296.13
+10.3%
-25.6%$24.43B$3.83B29.0018,000News Coverage
Positive News
Analyst Upgrade

Related Companies and Tools


This page (NASDAQ:BRKR) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners